Artwork

内容由Johns Hopkins Kimmel Cancer Center提供。所有播客内容(包括剧集、图形和播客描述)均由 Johns Hopkins Kimmel Cancer Center 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Cancer Matters with Dr Bill Nelson - FDA Approval of a Drug Targeting a Brain Cancer Mutation

13:17
 
分享
 

Manage episode 433007019 series 2310018
内容由Johns Hopkins Kimmel Cancer Center提供。所有播客内容(包括剧集、图形和播客描述)均由 Johns Hopkins Kimmel Cancer Center 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Dr Bill Nelson talks with Dr Matthias Holdhoff about the treatment of brain cancer and a significant FDA approval of a new drug treatment for a type of brain cancer, called low-grade glioma. The drug, called vorasidenib, is a targeted cancer therapy that works by inhibiting the activity of a mutated gene called IDH, slowing the growth of the cancer. Read more here

  continue reading

120集单集

Artwork
icon分享
 
Manage episode 433007019 series 2310018
内容由Johns Hopkins Kimmel Cancer Center提供。所有播客内容(包括剧集、图形和播客描述)均由 Johns Hopkins Kimmel Cancer Center 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Dr Bill Nelson talks with Dr Matthias Holdhoff about the treatment of brain cancer and a significant FDA approval of a new drug treatment for a type of brain cancer, called low-grade glioma. The drug, called vorasidenib, is a targeted cancer therapy that works by inhibiting the activity of a mutated gene called IDH, slowing the growth of the cancer. Read more here

  continue reading

120集单集

كل الحلقات

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南

边探索边听这个节目
播放